查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球腦磁圖市場 - 2023-2030 年
市場調查報告書
商品編碼
1319142

全球腦磁圖市場 - 2023-2030 年

Global Magnetoencephalography Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概述

全球腦磁圖市場規模在2022 年達到2.738 億美元，預計到2030 年將實現利潤豐厚的成長，達到4.088 億美元。在預測期內（2023-2030 年），全球腦磁圖市場預計將呈現5.2% 的年複合成長率。

腦磁圖對癲癇患者的檢查和手術規劃大有裨益。借助這項技術，可以找到致癇區，即導致癲癇發作的大腦活動異常的精確區域。這些資訊對選擇最佳手術方法至關重要，既能斷開或切除受損腦組織，又能保護關鍵功能區。

市場動態

在預測期內，對腦部研究的日益關注推動了全球腦磁圖市場的成長。

腦健康是一個不斷變化的概念，越來越受到健康產業和普通大眾的關注，這是有充分理由的。儘管阻止神經退行性病變導致晚年臨床失智症的最大策略是早期發現和控制風險因素，但對大腦健康危害的研究仍主要集中在中老年人身上。

以社區為基礎的腦健康管理服務為溝通和早期風險分析提供了新的機會。由此產生的大量數據將促進我們對失智症流行病學和治療效果的了解。

臨床診斷中越來越多的應用為全球腦磁圖市場提供了成長機會。

腦磁圖已被證明具有作為腦震盪臨床診斷技術的潛力。腦磁圖具有毫秒級的時間解析度，是一種繪製大腦功能解剖圖的非侵入性方法。它通過檢測神經元電活動產生的磁場來實現這一目的。軸突束產生的突觸後電位會產生具有磁場的細胞內電流，MEG 可以捕捉到這種電流。

MEG 利用遍布頭骨表面的高精度精密感測器捕捉磁場。無需X 射線、外部磁場或放射性同位素（用於核醫學），即可生成圖像。 MEG 能夠在位置和時間上區分正常和病態的大腦活動，是現有技術的一大進步。通過檢測磁場，可以以無與倫比的毫秒級時間解析度定位產生每個磁場的細胞組合。

COVID-19 影響分析

COVID-19 大流行對腦磁圖市場產生了重大影響。大流行導致供應鏈中斷、物流困難和財務不確定性。這些因素都可能導致腦磁圖系統的安裝和購置延遲。預算緊張的醫院、研究機構和診所，或因疫情而急需醫療保健服務的機構，可能會推遲或減少購買新的腦電圖設備。

俄烏衝突分析

俄烏戰爭對腦磁成像市場的影響是複雜和多方面的。由於衝突造成的混亂，疾病監測和篩查計劃難以成功實施。疾病監測和響應可能會受到阻礙，從而延誤流行病的識別和遏制。

目 錄

第1 章：研究方法與範圍

  • 研究方法
  • 報告的研究目標和範圍

第2章：定義和概述

第3章：執行摘要

  • 按應用分類
  • 按最終用戶分類
  • 按地區分類

第四章：動態

  • 影響因素
    • 促進因素
      • 失智症發病率上升
    • 制約因素
      • 與腦磁圖相關的挑戰
    • 機會
      • 在臨床診斷中的應用不斷增加
    • 影響分析

第5 章：行業分析

  • 波特五力分析
  • 供應鏈分析
  • 未滿足的需求
  • 監管分析

第6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情景
    • COVID-19 期間的情景
    • COVID-19 後的情況
  • COVID-19 期間的定價動態
  • 供需關係
  • 大流行期間與市場相關的政府計劃
  • 製造商的戰略計劃
  • 結論

第7 章：俄烏戰爭分析

第8章：人工智慧分析

第9章：按應用分類

  • 臨床
    • 失智症
    • 自閉症
    • 精神分裂症
    • 多發性硬化症
    • 中風
    • 癲癇
    • 其他
  • 研究

第10章：按最終用戶分類

  • 醫院
  • 影像診斷中心
  • 學術和研究機構

第11 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東和非洲

第12 章：競爭格局

  • 競爭格局
  • 產品基準
  • 公司佔有率分析
  • 主要發展和戰略

第13 章：公司簡介

  • Compumedics Limited
    • 公司概況
    • 產品組合和說明
    • 財務概況
    • 主要發展
  • MEGIN
  • Ricoh USA, Inc.
  • CTF MEG INTERNATIONAL SERVICES LP
  • FieldLine Inc.
  • Cerca Magnetics Limited
  • Croton healthcare

第14 章：附錄

簡介目錄
Product Code: MD6544

Market Overview

The global Magnetoencephalography Market reached US$ 273.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 408.8 million by 2030. The global Magnetoencephalography market is expected to exhibit a CAGR of 5.2% during the forecast period (2023-2030).

The examination and surgical planning of individuals with epilepsy benefit greatly from Magnetoencephalography. The epileptogenic zone the precise area of aberrant brain activity that causes seizures can be located with the aid of this technique. This information is essential for selecting the best surgical approach to disconnect or remove damaged brain tissue while protecting critical functional regions.

Market Dynamics

Increased focus on brain research is boosting the global magnetoencephalography market growth during the forecast period.

Brain health is a concept that is always changing, gaining attention from the health industry as well as from the general public, and it does so for good reasons. Despite the greatest strategy to stop neurodegenerative changes that lead to clinical dementia later in life is early detection and control of risk factors, research on hazards to brain health still focuses on middle-aged and older persons.

New chances for communicating and early risk profiling are offered by community-based services for managing brain health. Large volumes of data will be produced as a result, advancing our knowledge of the epidemiology of dementia and the effectiveness of therapies.

Increasing applications in clinical diagnostics provide global magnetoencephalography market growth opportunities.

MEG has demonstrated potential as a clinical diagnostic technique for concussion in some patients. With a millisecond time resolution, MEG is a non-invasive method of mapping the functional anatomy of the brain. It does this by detecting magnetic fields produced by neuronal electrical activity. Postsynaptic potentials generated by bundles of axons result in intracellular currents with a magnetic field that can be picked up by MEG.

Magnetic fields are captured by MEG using highly accurate and sophisticated sensors throughout the surface of the skull. Without the need for X-rays, external magnetic fields, or radioactive isotopes (used in nuclear medicine), images can be produced. In its capacity to distinguish between normal and pathological brain activity in location and time, MEG advances existing technology. The cell assemblies that create each field may be located with an unmatched millisecond temporal resolution by detecting the magnetic fields.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the magnetoencephalography market. The pandemic has caused supply chain disruptions, logistical difficulties, and financial uncertainty. These elements might have contributed to a delay in the installation and acquisition of MEG systems. Hospitals, research facilities, and clinics with tight budgets or those attending to the pressing healthcare need brought on by the epidemic may have delayed or scaled back purchases of new MEG equipment.

Russia-Ukraine Conflict Analysis

The impact of the Russia-Ukraine war on the magnetoencephalography market is complex and multifaceted. Because of the disruption caused by the conflict, illness surveillance, and screening initiatives are difficult to successfully implement. Disease surveillance and response could be hampered, which could delay the identification and containment of epidemics.

Segment Analysis

The global magnetoencephalography market is segmented based on application, end-user, and region.

The clinical segment is expected to hold a dominant position in the market over the forecast period.

The clinical segment accounted for the highest market stake accounting for approximately 57.8% of the Magnetoencephalography market in 2022. Around the world, Alzheimer's disease (AD) accounts for 60% of all occurrences of dementia, making it the most common cause of the illness. With age, there is a higher chance of acquiring AD. In terms of source localization, MEG clearly gives a benefit.

The potential of MEG to predict conversion across the several stages of the disease (preclinical-prodromal-dementia) is a key aspect to take into account when using MEG as a biomarker for AD. There aren't many longitudinal studies and those that do all addressed the transition from MCI to dementia.

Geographical Analysis

Advancements in magnetoencephalography dominate the European region.

Europe is expected to dominate the magnetoencephalography market, accounting for around 27.8% of this market. No external fields or injections are used in the MEG process; instead, it detects magnetic fields that the brain naturally produces. The most sophisticated clinical use of MEG is for epilepsy diagnosis.

Epilepsy affects six million individuals in Europe alone, and there are roughly 300,000 new cases every year. There are more applications for MEG, such as the diagnosis of mild traumatic brain injuries (TBI), which accounts for more than half of the 2.5 million new TBI cases in Europe each year.

Competitive Landscape

The major global players in the market include: Compumedics Limited, MEGIN, Ricoh USA, Inc., CTF MEG INTERNATIONAL SERVICES LP, FieldLine Inc., Cerca Magnetics Limited, and Croton Healthcare among others.

Why Purchase the Report?

  • To visualize the global magnetoencephalography market segmentation based on the application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of magnetoencephalography market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global magnetoencephalography market report would provide approximately 44 tables, 43 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Application
  • 3.2. Snippet by End-user
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The increasing incidence of dementia
    • 4.1.2. Restraints
      • 4.1.2.1. Challenges associated with magnetoencephalography
    • 4.1.3. Opportunity
      • 4.1.3.1. The increasing applications in clinical diagnostics
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Analysis

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Clinical*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 9.2.3. Dementia
    • 9.2.4. Autism
    • 9.2.5. Schizophrenia
    • 9.2.6. Multiple Sclerosis
    • 9.2.7. Stroke
    • 9.2.8. Epilepsy
    • 9.2.9. Others
  • 9.3. Research

10. By End-user

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 10.1.2. Market Attractiveness Index, By End-user
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Diagnostic Imaging centers
  • 10.4. Academic and Research Institutes

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.5.1. U.S.
      • 11.2.5.2. Canada
      • 11.2.5.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.5.1. Germany
      • 11.3.5.2. U.K.
      • 11.3.5.3. France
      • 11.3.5.4. Italy
      • 11.3.5.5. Spain
      • 11.3.5.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.5.1. Brazil
      • 11.4.5.2. Argentina
      • 11.4.5.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.5.1. China
      • 11.5.5.2. India
      • 11.5.5.3. Japan
      • 11.5.5.4. Australia
      • 11.5.5.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Product Benchmarking
  • 12.3. Company Share Analysis
  • 12.4. Key Developments and Strategies

13. Company Profiles

  • 13.1. Compumedics Limited*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. MEGIN
  • 13.3. Ricoh USA, Inc.
  • 13.4. CTF MEG INTERNATIONAL SERVICES LP
  • 13.5. FieldLine Inc.
  • 13.6. Cerca Magnetics Limited
  • 13.7. Croton healthcare

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us